546 related articles for article (PubMed ID: 17244200)
1. Changes in the expression of corticotrophin-releasing hormone, mineralocorticoid receptor and glucocorticoid receptor mRNAs in the hypothalamic paraventricular nucleus induced by fornix transection and adrenalectomy.
Han F; Ozawa H; Matsuda KI; Lu H; De Kloet ER; Kawata M
J Neuroendocrinol; 2007 Apr; 19(4):229-38. PubMed ID: 17244200
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
Makino S; Smith MA; Gold PW
Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
[TBL] [Abstract][Full Text] [Related]
3. CRH mRNA expression in the hypothalamic paraventricular nucleus is inhibited despite the activation of the hypothalamo-pituitary-adrenal axis during starvation.
Nishiyama M; Makino S; Iwasaki Y; Tanaka Y; Nazarloo HP; Kaneda T; Asaba K; Hashimoto K
Brain Res; 2008 Sep; 1228():107-12. PubMed ID: 18619422
[TBL] [Abstract][Full Text] [Related]
4. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
[TBL] [Abstract][Full Text] [Related]
5. Lack of decrease in hypothalamic and hippocampal glucocorticoid receptor mRNA during starvation.
Makino S; Kaneda T; Nishiyama M; Asaba K; Hashimoto K
Neuroendocrinology; 2001 Aug; 74(2):120-8. PubMed ID: 11474219
[TBL] [Abstract][Full Text] [Related]
6. Endurance treadmill training in rats alters CRH activity in the hypothalamic paraventricular nucleus at rest and during acute running according to its period.
Kawashima H; Saito T; Yoshizato H; Fujikawa T; Sato Y; McEwen BS; Soya H
Life Sci; 2004 Dec; 76(7):763-74. PubMed ID: 15581908
[TBL] [Abstract][Full Text] [Related]
7. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.
Brady LS; Whitfield HJ; Fox RJ; Gold PW; Herkenham M
J Clin Invest; 1991 Mar; 87(3):831-7. PubMed ID: 1671867
[TBL] [Abstract][Full Text] [Related]
8. Modulation of oestrogen receptor-beta mRNA expression in rat paraventricular and supraoptic nucleus neurones following adrenal steroid manipulation and hyperosmotic stimulation.
Somponpun SJ; Holmes MC; Seckl JR; Russell JA
J Neuroendocrinol; 2004 May; 16(5):472-82. PubMed ID: 15117341
[TBL] [Abstract][Full Text] [Related]
9. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.
Swanson LW; Simmons DM
J Comp Neurol; 1989 Jul; 285(4):413-35. PubMed ID: 2569487
[TBL] [Abstract][Full Text] [Related]
10. Characterization of central and peripheral components of the hypothalamus-pituitary-adrenal axis in the inbred Roman rat strains.
Carrasco J; Márquez C; Nadal R; Tobeña A; Fernández-Teruel A; Armario A
Psychoneuroendocrinology; 2008 May; 33(4):437-45. PubMed ID: 18276081
[TBL] [Abstract][Full Text] [Related]
11. Central regulation of the hypothalamic-pituitary-adrenal axis during fetal development in the Guinea-pig.
Owen D; Banjanin S; Gidrewicz D; McCabe L; Matthews SG
J Neuroendocrinol; 2005 Apr; 17(4):220-6. PubMed ID: 15842233
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor.
Uchida S; Nishida A; Hara K; Kamemoto T; Suetsugi M; Fujimoto M; Watanuki T; Wakabayashi Y; Otsuki K; McEwen BS; Watanabe Y
Eur J Neurosci; 2008 May; 27(9):2250-61. PubMed ID: 18445216
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of mineralocorticoid receptor and glucocorticoid receptor in the hippocampus and hypothalamus.
Han F; Ozawa H; Matsuda K; Nishi M; Kawata M
Neurosci Res; 2005 Apr; 51(4):371-81. PubMed ID: 15740800
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions.
Aguilar-Valles A; Sánchez E; de Gortari P; Balderas I; Ramírez-Amaya V; Bermúdez-Rattoni F; Joseph-Bravo P
Neuroendocrinology; 2005; 82(5-6):306-19. PubMed ID: 16721035
[TBL] [Abstract][Full Text] [Related]
15. Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis.
Inouye KE; Chan O; Yue JT; Matthews SG; Vranic M
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E422-9. PubMed ID: 15494609
[TBL] [Abstract][Full Text] [Related]
16. Age- and stress-induced changes in corticotropin-releasing hormone mRNA expression in the paraventricular nucleus of the hypothalamus.
Romeo RD; Karatsoreos IN; Jasnow AM; McEwen BS
Neuroendocrinology; 2007; 85(4):199-206. PubMed ID: 17505125
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids down-regulate lipopolysaccharide-induced de novo production of neurotensin mRNA in the rat hypothalamic, paraventricular, corticotrophin-releasing hormone neurons.
Loum-Ribot E; Lafon P; Chaigniau M; Tramu G; Corio M
Neuroimmunomodulation; 2006; 13(3):170-8. PubMed ID: 17183192
[TBL] [Abstract][Full Text] [Related]
18. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
Herman JP; Wiegand SJ; Watson SJ
Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
[TBL] [Abstract][Full Text] [Related]
19. Differential neuroendocrine responses to chronic variable stress in adult Long Evans rats exposed to handling-maternal separation as neonates.
Ladd CO; Thrivikraman KV; Huot RL; Plotsky PM
Psychoneuroendocrinology; 2005 Jul; 30(6):520-33. PubMed ID: 15808921
[TBL] [Abstract][Full Text] [Related]
20. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
